Skip to content

Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study

Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01705288
Enrollment
103
Registered
2012-10-12
Start date
2013-01-01
Completion date
2016-08-24
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer, Uterine Endometrial Cancer, Ovarian Cancer

Keywords

laparotomy, hysterectomy

Brief summary

Over 600,000 hysterectomies are performed annually in the United States. Despite increasing use of less invasive approaches, the majority of hysterectomies are still performed via traditional laparotomy, which can be associated with generally slower recovery and longer lengths of post-operative hospitalization. Rapid Recovery Protocols (RRP) seek to optimize post-surgical morbidity outcomes by returning a patient to normal physiology as quickly as possible following surgery.

Detailed description

Subjects will be randomly assigned to one of two groups: Rapid recovery protocol (regional anesthesia, pain control options with emphasis on nonsteroidal anti-inflammatory drugs (NSAIDS) over narcotic pain medications, early ambulation, and early enteral feeding) or standard of care (traditional laparatomy and supportive care).

Interventions

PROCEDURELaparotomy

Exploratory surgery for gynecologic diagnosis.Involves pre-operative counseling, the use of regional anesthesia (spinal or epidural pain management rather than intravenous narcotics), early eating after surgery, early walking, and certain goals for discharge from the hospital

given for pain management after surgery per physician orders

inhalant or intravenous during surgery

DRUGregional anesthesia

given by spinal or epidural infusion

given for pain management after surgery

Sponsors

Masonic Cancer Center, University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Women who are being seen at the Women's Health Center by the Gynecologic Oncology group at the University of Minnesota if planned surgery includes an exploratory laparotomy

Exclusion criteria

* \< 19 years old * Pregnant * Undergoing a procedure other than laparotomy * Scheduled to be discharged the same day of surgery * Chronic narcotic pain medication user * American Society of Anesthesiologists (ASA) score of \> or = 3 * Any condition that would exclude women from undergoing regional anesthesia

Design outcomes

Primary

MeasureTime frameDescription
Hospital Stay1 MonthLength of hospital stay for patients undergoing laparotomy on the gynecologic oncology service measured as whole days from the day of surgery until discharge

Secondary

MeasureTime frameDescription
Pain Medications UsedPost operative - day 2Total daily narcotic pain medication used by patients. Narcotic use was standardized by conversion to morphine equivalents using the methods of Korff et al.
Pain AssessmentDay 0Secondary outcome is to determine if rapid recovery can improve Visual Analogue Scale (VAS) for pain assessment. VAS scales are a horizontal line 100 mm in length with the left end labeled 'No pain' and the right end labeled 'Very severe pain'. The subject marks a point on the line that represents their perception of their current state. VAS score is determined by measuring the distance (mm) from the left end of the line to the point on the line marked by the subject. The range of possible values for this pain score is 0 to 100 mm.

Countries

United States

Participant flow

Participants by arm

ArmCount
Control Group (Standard Laparotomy)
Patients undergoing standard anesthesia and standard exploratory laparotomy. Treatment will be per your surgeon's routine standards. Laparotomy: Exploratory surgery for gynecologic diagnosis.Involves pre-operative counseling, the use of regional anesthesia (spinal or epidural pain management rather than intravenous narcotics), early eating after surgery, early walking, and certain goals for discharge from the hospital intravenous narcotics: given for pain management after surgery per physician orders standard anesthesia: inhalant or intravenous during surgery
52
Rapid Recovery Group
Protocol for rapid recovery laparotomy procedure involves pre-operative counseling, the use of regional anesthesia (spinal or epidural pain management rather than intravenous narcotics), post-operative use of non-steroidal anti-inflammatory drugs, early eating after surgery, early walking, and certain goals for discharge from the hospital. Laparotomy: Exploratory surgery for gynecologic diagnosis.Involves pre-operative counseling, the use of regional anesthesia (spinal or epidural pain management rather than intravenous narcotics), early eating after surgery, early walking, and certain goals for discharge from the hospital regional anesthesia: given by spinal or epidural infusion Non-steroidal anti-inflammatory drugs: given for pain management after surgery
51
Total103

Baseline characteristics

CharacteristicRapid Recovery GroupControl Group (Standard Laparotomy)Total
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
51 Participants52 Participants103 Participants
Age, Continuous55.4 years56.0 years55.65 years
Region of Enrollment
United States
51 participants52 participants103 participants
Sex: Female, Male
Female
51 Participants52 Participants103 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
4 / 527 / 51
serious
Total, serious adverse events
1 / 524 / 51

Outcome results

Primary

Hospital Stay

Length of hospital stay for patients undergoing laparotomy on the gynecologic oncology service measured as whole days from the day of surgery until discharge

Time frame: 1 Month

Population: Individuals randomized who underwent eligible surgery

ArmMeasureValue (MEDIAN)
Control Group (Standard Laparotomy)Hospital Stay3.0 Days
Rapid Recovery GroupHospital Stay3.0 Days
Comparison: Intention to Treat Analysisp-value: 0.36Wilcoxon (Mann-Whitney)
Secondary

Pain Assessment

Secondary outcome is to determine if rapid recovery can improve Visual Analogue Scale (VAS) for pain assessment. VAS scales are a horizontal line 100 mm in length with the left end labeled 'No pain' and the right end labeled 'Very severe pain'. The subject marks a point on the line that represents their perception of their current state. VAS score is determined by measuring the distance (mm) from the left end of the line to the point on the line marked by the subject. The range of possible values for this pain score is 0 to 100 mm.

Time frame: Day 0

Population: Measured in early patients only

ArmMeasureValue (MEDIAN)
Control Group (Standard Laparotomy)Pain Assessment4.33 Score on a scale
Rapid Recovery GroupPain Assessment3.13 Score on a scale
p-value: 0.18Wilcoxon (Mann-Whitney)
Secondary

Pain Medications Used

Total daily narcotic pain medication used by patients. Narcotic use was standardized by conversion to morphine equivalents using the methods of Korff et al.

Time frame: Post operative - day 2

ArmMeasureValue (MEDIAN)
Control Group (Standard Laparotomy)Pain Medications Used10.0 Morphine equivalents
Rapid Recovery GroupPain Medications Used7.5 Morphine equivalents
Comparison: Intention to Treat Analysisp-value: 0.05Wilcoxon (Mann-Whitney)

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026